Induction chemotherapy in locally advanced head and neck cancers, is there a best choice?
-
Published:2023-06
Issue:
Volume:186
Page:103986
-
ISSN:1040-8428
-
Container-title:Critical Reviews in Oncology/Hematology
-
language:en
-
Short-container-title:Critical Reviews in Oncology/Hematology
Subject
Oncology,Hematology
Reference90 articles.
1. Early prediction of survival following induction chemotherapy with DCF (docetaxel, cisplatin, 5-fluorouracil) using FDG PET/CT imaging in patients with locally advanced head and neck squamous cell carcinoma;Abgral;Eur. J. Nucl. Med. Mol. Imaging,2012
2. TPF induction chemotherapy increases PD-L1 expression in tumour cells and immune cells in head and neck squamous cell carcinoma;Adam;ESMO Open,2018
3. nab-Paclitaxel, cisplatin, and 5-fluorouracil followed by concurrent cisplatin and radiation for head and neck squamous cell carcinoma;Adkins;Oral. Oncol.,2016
4. Induction chemotherapy with cetuximab, carboplatin and paclitaxel for the treatment of locally advanced squamous cell carcinoma of the head and neck;Bauman;Exp. Ther. Med.,2013
5. Differences and similarities in the pattern of early metabolic and morphologic response after induction chemo-immunotherapy versus induction chemotherapy alone in locally advanced squamous cell head and neck cancer;Beck;Cancers,2022
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献